Carol Campbell v. Boston Scientific Corporation
882 F.3d 70
4th Cir.2018Background
- Four consolidated West Virginia products-liability cases (part of MDL No. 2326) involved women implanted with Boston Scientific’s Obtryx transobturator mid-urethral sling who alleged severe complications (pain, dyspareunia, erosion, voiding dysfunction) requiring additional surgeries.
- Obtryx was FDA-cleared in 2004 via the 510(k) process; its directions for use warned generally about complications.
- Obtryx is made from Marlex polypropylene; the Marlex MSDS contained a caution against permanent implantation.
- The district court consolidated eleven cases for trial (later four remained); BSC moved unsuccessfully to try the four cases separately.
- At trial the court excluded evidence about the FDA 510(k) process but admitted the Marlex MSDS caution.
- Jury returned multi-million dollar compensatory and $1,000,000 punitive awards to each plaintiff; BSC appealed consolidation, evidentiary rulings, sufficiency of evidence, and punitive-damages instruction.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Consolidation under Rule 42(a) | Consolidation appropriate because common questions of law/fact and efficiency; safeguards prevented prejudice | Consolidation unfairly prejudiced BSC; evidence admissible for some plaintiffs only confused jury | Affirmed: no abuse of discretion; common issues predominated and court gave limiting instructions/special interrogatories |
| Admissibility of FDA 510(k) evidence | Plaintiffs sought to exclude; generally argued 510(k) not dispositive | BSC argued 510(k) proves product safety and reasonableness of conduct | Affirmed exclusion under Rule 403: 510(k) has limited, potentially confusing probative value |
| Admissibility of Marlex MSDS caution | MSDS shows manufacturer’s concern and BSC’s knowledge; not offered for truth | BSC argued MSDS was hearsay and inadmissible | Affirmed admission: not hearsay because offered to show notice/state of mind, not truth of the caution |
| Sufficiency of evidence (design-defect & failure-to-warn) | Plaintiffs presented expert/medical testimony that Obtryx degraded, caused injuries, and warnings were inadequate | BSC argued lack of specific design defect, lack of safer-alternative proof, and no expert proving warnings inadequate | Affirmed: substantial evidence supported both theories; jury reasonably could find defect and inadequate warnings (expert and physician testimony sufficed) |
| Punitive damages standard | Plaintiffs applied preponderance standard consistent with WV precedent at trial | BSC argued clear-and-convincing standard required | Affirmed: trial instruction matched West Virginia law at the time (preponderance), so no reversible error |
Key Cases Cited
- Arnold v. Eastern Air Lines, Inc., 681 F.2d 186 (4th Cir. 1982) (factors for Rule 42(a) consolidation analysis)
- Cisson v. C.R. Bard, Inc., 810 F.3d 913 (4th Cir. 2016) (exclusion/admission of 510(k) and MSDS evidence in mesh litigation)
- Huskey v. Ethicon, Inc., 848 F.3d 151 (4th Cir. 2017) (reaffirming Cisson on 510(k) evidence)
- Cavazos v. Smith, 565 U.S. 1 (2011) (standard for reviewing sufficiency of the evidence)
- United States v. Powell, 469 U.S. 57 (1984) (courts should not probe jury deliberations for inconsistency)
- Nease v. Ford Motor Co., 848 F.3d 219 (4th Cir. 2017) (discussing reasonable alternative design under WV law)
- Morningstar v. Black & Decker Mfg. Co., 253 S.E.2d 666 (W. Va. 1979) (product-defect framework and role of expert testimony)
- Goodwin v. Thomas, 403 S.E.2d 13 (W. Va. 1991) (state decisions applying preponderance standard for punitive-damages instructions)
- Coleman v. Sopher, 499 S.E.2d 592 (W. Va. 1997) (rejecting contention that clear-and-convincing required before submitting punitive damages to jury)